FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972245712> ?p ?o ?g. }

• W1972245712 endingPage "990" @default.
• W1972245712 startingPage "981" @default.
• W1972245712 abstract "2′,2′-Difluorodeoxycytidine (gemcitabine, dFdC) and cis-diammine-dichloroplatinum (cisplatin, CDDP) are active agents against ovarian cancer and non-small-cell lung cancer (NSCLC). CDDP acts by formation of platinum (Pt)–DNA adducts; dFdC by dFdCTP incorporation into DNA, subsequently leading to inhibition of exonuclease and DNA repair. Previously, synergism between both compounds was found in several human and murine cancer cell lines when cells were treated with these drugs in a constant ratio. In the present study we used different combinations of both drugs (one drug at its IC25 and the other in a concentration range) in the human ovarian cancer cell line A2780, its CDDP-resistant variant ADDP, its dFdC-resistant variant AG6000 and two NSCLC cell lines, H322 (human) and Lewis lung (LL) (murine). Cells were exposed for 4, 24 and 72 h with a total culture time of 96 h, and possible synergism was evaluated by median drug effect analysis by calculating a combination index (CI; CI < 1 indicates synergism). With CDDP at its IC25, the average CIs calculated at the IC50, IC75 IC90 and IC95 after 4, 24 and 72 h of exposure were < 1 for all cell lines, indicating synergism, except for the CI after 4 h exposure in the LL cell line which showed an additive effect. With dFdC at its IC25, the CIs for the combination with CDDP after 24 h were < 1 in all cell lines, except for the Cls after 4 h exposure in the LL and H322 cell lines which showed an additive effect. At 72 h exposure all Cls were < 1. CDDP did not significantly affect dFdCTP accumulation in all cell lines. CDDP increased dFdC incorporation into both DNA and RNA of the A2780 cell lines 33- and 79-fold (P < 0.01) respectively, and tended to increase the dFdC incorporation into RNA in all cell lines. In the AG6000 and LL cell lines, CDDP and dFdC induced > 25% more DNA strand breaks (DSB) than each drug alone; however, in the other cell lines no effect, or even a decrease in DSB, was observed. dFdC increased the cellular Pt accumulation after 24 h incubation only in the ADDP cell line. However, dFdC did enhance the Pt–DNA adduct formation in the A2780, AG6000, ADDP and LL cell lines (1.6-, 1.4-, 2.9- and 1.6-fold respectively). This increase in Pt–DNA adduct formation seems to be related to the incorporation of dFdC into DNA (r = 0.91). No increase in DNA platination was found in the H322 cell line. dFdC only increased Pt–DNA adduct retention in the A2780 and LL cell lines, but decreased the Pt–DNA adduct retention in the AG6000 cell line. In conclusion, the synergism between dFdC and CDDP appears to be mainly due to an increase in Pt–DNA adduct formation possibly related to changes in DNA due to dFdC incorporation into DNA." @default.
• W1972245712 created "2016-06-24" @default.
• W1972245712 creator A5001534904 @default.
• W1972245712 creator A5007067879 @default.
• W1972245712 creator A5025611128 @default.
• W1972245712 creator A5031117246 @default.
• W1972245712 creator A5031401973 @default.
• W1972245712 creator A5035296183 @default.
• W1972245712 creator A5049129917 @default.
• W1972245712 creator A5062035206 @default.
• W1972245712 date "1999-05-07" @default.
• W1972245712 modified "2023-10-12" @default.
• W1972245712 title "Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines" @default.
• W1972245712 cites W1527742565 @default.
• W1972245712 cites W1577193978 @default.
• W1972245712 cites W1890647543 @default.
• W1972245712 cites W1905254767 @default.
• W1972245712 cites W1938837918 @default.
• W1972245712 cites W1964833598 @default.
• W1972245712 cites W1969848098 @default.
• W1972245712 cites W1971149131 @default.
• W1972245712 cites W1977515504 @default.
• W1972245712 cites W1990729996 @default.
• W1972245712 cites W2003813442 @default.
• W1972245712 cites W2014896394 @default.
• W1972245712 cites W2017471791 @default.
• W1972245712 cites W2024152133 @default.
• W1972245712 cites W2034233680 @default.
• W1972245712 cites W2041337400 @default.
• W1972245712 cites W2051956047 @default.
• W1972245712 cites W2060932390 @default.
• W1972245712 cites W2077945404 @default.
• W1972245712 cites W2078988395 @default.
• W1972245712 cites W2083470546 @default.
• W1972245712 cites W2125626986 @default.
• W1972245712 cites W2129793148 @default.
• W1972245712 cites W2135146886 @default.
• W1972245712 cites W2138468010 @default.
• W1972245712 cites W2139204427 @default.
• W1972245712 cites W2154498516 @default.
• W1972245712 cites W2155208683 @default.
• W1972245712 cites W2160610387 @default.
• W1972245712 cites W2168555194 @default.
• W1972245712 cites W2260156774 @default.
• W1972245712 cites W2262092684 @default.
• W1972245712 cites W2394913170 @default.
• W1972245712 doi "https://doi.org/10.1038/sj.bjc.6690452" @default.
• W1972245712 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2363050" @default.
• W1972245712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10362105" @default.
• W1972245712 hasPublicationYear "1999" @default.
• W1972245712 type Work @default.
• W1972245712 sameAs 1972245712 @default.
• W1972245712 citedByCount "175" @default.
• W1972245712 countsByYear W19722457122012 @default.
• W1972245712 countsByYear W19722457122013 @default.
• W1972245712 countsByYear W19722457122014 @default.
• W1972245712 countsByYear W19722457122015 @default.
• W1972245712 countsByYear W19722457122016 @default.
• W1972245712 countsByYear W19722457122017 @default.
• W1972245712 countsByYear W19722457122018 @default.
• W1972245712 countsByYear W19722457122019 @default.
• W1972245712 countsByYear W19722457122020 @default.
• W1972245712 countsByYear W19722457122021 @default.
• W1972245712 countsByYear W19722457122022 @default.
• W1972245712 countsByYear W19722457122023 @default.
• W1972245712 crossrefType "journal-article" @default.
• W1972245712 hasAuthorship W1972245712A5001534904 @default.
• W1972245712 hasAuthorship W1972245712A5007067879 @default.
• W1972245712 hasAuthorship W1972245712A5025611128 @default.
• W1972245712 hasAuthorship W1972245712A5031117246 @default.
• W1972245712 hasAuthorship W1972245712A5031401973 @default.
• W1972245712 hasAuthorship W1972245712A5035296183 @default.
• W1972245712 hasAuthorship W1972245712A5049129917 @default.
• W1972245712 hasAuthorship W1972245712A5062035206 @default.
• W1972245712 hasBestOaLocation W19722457121 @default.
• W1972245712 hasConcept C121608353 @default.
• W1972245712 hasConcept C126322002 @default.
• W1972245712 hasConcept C1491633281 @default.
• W1972245712 hasConcept C153911025 @default.
• W1972245712 hasConcept C185592680 @default.
• W1972245712 hasConcept C2776256026 @default.
• W1972245712 hasConcept C2776694085 @default.
• W1972245712 hasConcept C2778239845 @default.
• W1972245712 hasConcept C2780258809 @default.
• W1972245712 hasConcept C2780427987 @default.
• W1972245712 hasConcept C502942594 @default.
• W1972245712 hasConcept C54355233 @default.
• W1972245712 hasConcept C55493867 @default.
• W1972245712 hasConcept C62112901 @default.
• W1972245712 hasConcept C71924100 @default.
• W1972245712 hasConcept C81885089 @default.
• W1972245712 hasConcept C86803240 @default.
• W1972245712 hasConcept C98274493 @default.
• W1972245712 hasConceptScore W1972245712C121608353 @default.
• W1972245712 hasConceptScore W1972245712C126322002 @default.
• W1972245712 hasConceptScore W1972245712C1491633281 @default.
• W1972245712 hasConceptScore W1972245712C153911025 @default.
• W1972245712 hasConceptScore W1972245712C185592680 @default.

• next